Patent reform bill to protect innovation, confront abuse introduced in USA

4 March 2015
medical_legal_law_big

US Senators Chris Coons (Democrat, Delaware) and Dick Durbin (Democrat, Illinois), members of the Senate Judiciary Committee, and Mazie Hirono (Democrat, Hawaii), member of the Senate Committee on Small Business and Entrepreneurship, have introduced legislation to strengthen America’s patent system and target abusers.

Titled The STRONG Patents Act, this takes a series of focused, thoughtful steps to make the patent system work for individual inventors and research-intensive companies from every sector of the economy. It would make it harder for firms to be targeted with frivolous patent lawsuits, level the playing field between small inventors and large companies, and ensure the US Patent and Trademark Office has the resources it needs to ensure patent quality.

The STRONG Patents Act would strengthen the US patent system and combat abuse by:

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical